{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T18:03:56Z","timestamp":1763661836455},"reference-count":89,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.mcna.2011.11.006","type":"journal-article","created":{"date-parts":[[2012,3,5]],"date-time":"2012-03-05T22:21:46Z","timestamp":1330986106000},"page":"39-55","source":"Crossref","is-referenced-by-count":15,"title":["Triglycerides: How Much Credit Do They Deserve?"],"prefix":"10.1016","volume":"96","author":[{"given":"Payal","family":"Kohli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher P.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.mcna.2011.11.006_bib1","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJM198006193022503","article-title":"Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease","volume":"302","author":"Hulley","year":"1980","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.mcna.2011.11.006_bib2","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"issue":"9607","key":"10.1016\/j.mcna.2011.11.006_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"371","author":"Kearney","year":"2008","journal-title":"Lancet"},{"issue":"Suppl 10","key":"10.1016\/j.mcna.2011.11.006_bib4","doi-asserted-by":"crossref","first-page":"1K","DOI":"10.1016\/j.amjcard.2008.10.002","article-title":"The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia","volume":"102","author":"Fruchart","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.mcna.2011.11.006_bib5","series-title":"Medicine A, vol. 1","article-title":"Diagnosis and treatment of dyslipidemia","author":"Brunzell","year":"2006"},{"issue":"6","key":"10.1016\/j.mcna.2011.11.006_bib6","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/archinternmed.2008.599","article-title":"Hypertriglyceridemia and its pharmacologic treatment among US adults","volume":"169","author":"Ford","year":"2009","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.mcna.2011.11.006_bib7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0889-8529(05)70023-2","article-title":"Lipoprotein physiology","volume":"27","author":"Ginsberg","year":"1998","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"16","key":"10.1016\/j.mcna.2011.11.006_bib8","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1161\/01.CIR.0000035280.64322.31","article-title":"New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism","volume":"106","author":"Ginsberg","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.mcna.2011.11.006_bib9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/hrt.2010.204990","article-title":"Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient","volume":"97","author":"Watts","year":"2011","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.mcna.2011.11.006_bib10","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00125-003-1111-y","article-title":"Diabetic dyslipidaemia: from basic research to clinical practice","volume":"46","author":"Taskinen","year":"2003","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.mcna.2011.11.006_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/MOL.0b013e32832dd4dc","article-title":"Triglycerides and coronary heart disease: have recent insights yielded conclusive answers?","volume":"20","author":"Sarwar","year":"2009","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"10.1016\/j.mcna.2011.11.006_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.106.675355","article-title":"Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study","volume":"116","author":"Fox","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.mcna.2011.11.006_bib13","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2337\/diacare.26.5.1413","article-title":"Visceral adipose tissue cutoffs associated with metabolic risk factors for coronary heart disease in women","volume":"26","author":"Nicklas","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mcna.2011.11.006_bib14","series-title":"Braunwald\u2019s heart disease: a textbook of cardiovascular medicine","year":"2012"},{"issue":"9726","key":"10.1016\/j.mcna.2011.11.006_bib15","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0140-6736(10)60545-4","article-title":"Triglyceride-mediated pathways and coronary\u00a0disease: collaborative analysis of 101 studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.mcna.2011.11.006_bib16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"issue":"4A","key":"10.1016\/j.mcna.2011.11.006_bib17","doi-asserted-by":"crossref","first-page":"18B","DOI":"10.1016\/S0002-9149(98)00033-2","article-title":"Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome","volume":"81","author":"Grundy","year":"1998","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.mcna.2011.11.006_bib18","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.cjca.2011.03.014","article-title":"Vascular disease risk in patients with hypertriglyceridemia: endothelial progenitor cells, oxidative stress, accelerated senescence, and impaired vascular repair","volume":"27","author":"Thorin","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.mcna.2011.11.006_bib19","doi-asserted-by":"crossref","first-page":"D332","DOI":"10.2741\/Yu","article-title":"Postprandial lipoproteins and atherosclerosis","volume":"6","author":"Yu","year":"2001","journal-title":"Front Biosci"},{"issue":"4","key":"10.1016\/j.mcna.2011.11.006_bib20","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0002-9343(93)90144-E","article-title":"Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B","volume":"94","author":"Chait","year":"1993","journal-title":"Am J Med"},{"issue":"8A","key":"10.1016\/j.mcna.2011.11.006_bib21","doi-asserted-by":"crossref","first-page":"30i","DOI":"10.1016\/S0002-9149(02)02749-2","article-title":"Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity","volume":"90","author":"Kwiterovich","year":"2002","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.mcna.2011.11.006_bib22","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1074\/jbc.M008725200","article-title":"Elevated triglyceride content diminishes the capacity of high density lipoprotein to deliver cholesteryl esters via the scavenger receptor class B type I (SR-BI)","volume":"276","author":"Greene","year":"2001","journal-title":"J\u00a0Biol Chem"},{"issue":"8","key":"10.1016\/j.mcna.2011.11.006_bib23","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1194\/jlr.M100431-JLR200","article-title":"LDL and HDL enriched in triglyceride promote abnormal cholesterol transport","volume":"43","author":"Skeggs","year":"2002","journal-title":"J\u00a0Lipid Res"},{"issue":"6","key":"10.1016\/j.mcna.2011.11.006_bib24","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1161\/01.CIR.85.6.2065","article-title":"Role of family history in patients with myocardial infarction. An Italian case-control study. GISSI-EFRIM investigators","volume":"85","author":"Roncaglioni","year":"1992","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.mcna.2011.11.006_bib25","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1161\/01.CIR.85.6.2025","article-title":"Familial lipoprotein disorders in patients with premature coronary artery disease","volume":"85","author":"Genest","year":"1992","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.mcna.2011.11.006_bib26","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJM199304293281702","article-title":"Plasma triglyceride level and mortality from coronary heart disease","volume":"328","author":"Criqui","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.mcna.2011.11.006_bib27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00043798-199604000-00014","article-title":"Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies","volume":"3","author":"Hokanson","year":"1996","journal-title":"J\u00a0Cardiovasc Risk"},{"issue":"17","key":"10.1016\/j.mcna.2011.11.006_bib28","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1161\/01.CIR.0000145615.33955.83","article-title":"Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region","volume":"110","author":"Patel","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.mcna.2011.11.006_bib29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.7326\/0003-4819-147-6-200709180-00007","article-title":"Changes in triglyceride levels and risk for coronary heart disease in young men","volume":"147","author":"Tirosh","year":"2007","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.mcna.2011.11.006_bib30","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.amjcard.2010.05.002","article-title":"Contribution of high plasma triglycerides and low high-density lipoprotein cholesterol to residual risk of coronary heart disease after establishment of low-density lipoprotein cholesterol control","volume":"106","author":"Carey","year":"2010","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.mcna.2011.11.006_bib31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.amjcard.2009.04.008","article-title":"Plasma triglycerides and cardiovascular events in the treating to new targets and incremental decrease in end-points through aggressive lipid lowering trials of statins in patients with coronary artery disease","volume":"104","author":"Faergeman","year":"2009","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.mcna.2011.11.006_bib32","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jacc.2007.10.038","article-title":"Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial","volume":"51","author":"Miller","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.mcna.2011.11.006_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/01.CIR.85.1.37","article-title":"Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment","volume":"85","author":"Manninen","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2011.11.006_bib34","first-page":"2789","article-title":"Familial lipoprotein lipase deficiency, apo cIII deficiency and hepatic lipase deficiency","volume":"vol. 3","author":"Brunzell","year":"2000"},{"key":"10.1016\/j.mcna.2011.11.006_bib35","first-page":"245","article-title":"The interaction of familial and secondary causes of hypertriglyceridemia: role in pancreatitis","volume":"86","author":"Brunzell","year":"1973","journal-title":"Trans Assoc Am Physicians"},{"issue":"2","key":"10.1016\/j.mcna.2011.11.006_bib36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jacc.2004.10.031","article-title":"Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials","volume":"45","author":"Birjmohun","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.mcna.2011.11.006_bib37","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1210\/jc.85.3.977","article-title":"Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men","volume":"85","author":"Purnell","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.mcna.2011.11.006_bib38","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.mcna.2011.11.006_bib39","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1161\/01.ATV.0000238352.25222.5e","article-title":"Summary of American Heart Association diet and lifestyle recommendations revision 2006","volume":"26","author":"Lichtenstein","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.mcna.2011.11.006_bib40","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/CIRCULATIONAHA.106.176158","article-title":"Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee","volume":"114","author":"Lichtenstein","year":"2006","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.mcna.2011.11.006_bib41","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMcp070061","article-title":"Clinical practice. Hypertriglyceridemia","volume":"357","author":"Brunzell","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 6","key":"10.1016\/j.mcna.2011.11.006_bib42","doi-asserted-by":"crossref","first-page":"S502","DOI":"10.1097\/00005768-200106001-00021","article-title":"Response of blood lipids to exercise training alone or combined with dietary intervention","volume":"33","author":"Leon","year":"2001","journal-title":"Med Sci Sports Exerc"},{"issue":"2","key":"10.1016\/j.mcna.2011.11.006_bib43","doi-asserted-by":"crossref","first-page":"92","DOI":"10.7326\/0003-4819-133-2-200007180-00008","article-title":"Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial","volume":"133","author":"Ross","year":"2000","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.mcna.2011.11.006_bib44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1753-4887.2005.tb00132.x","article-title":"Dietary fructose: implications for dysregulation of energy homeostasis and lipid\/carbohydrate metabolism","volume":"63","author":"Havel","year":"2005","journal-title":"Nutr Rev"},{"issue":"1","key":"10.1016\/j.mcna.2011.11.006_bib45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/01.ATV.1.1.13","article-title":"Levels and interrelationships of serum and lipoprotein cholesterol and triglycerides. Association with adiposity and the consumption of ethanol, tobacco, and beverages containing caffeine","volume":"1","author":"Phillips","year":"1981","journal-title":"Arteriosclerosis"},{"issue":"1","key":"10.1016\/j.mcna.2011.11.006_bib46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1517\/14656566.2010.502529","article-title":"Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies","volume":"12","author":"Chan","year":"2011","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"10.1016\/j.mcna.2011.11.006_bib47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.mcna.2011.11.006_bib48","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.jacc.2009.09.010","volume":"54","author":"Gibson","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.mcna.2011.11.006_bib49","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2337\/dc05-2465","article-title":"Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study","volume":"29","author":"Shepherd","year":"2006","journal-title":"Diabetes Care"},{"issue":"9435","key":"10.1016\/j.mcna.2011.11.006_bib50","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.mcna.2011.11.006_bib51","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","article-title":"Effects of combination lipid therapy in type 2 diabetes mellitus","volume":"362","author":"Ginsberg","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"9729","key":"10.1016\/j.mcna.2011.11.006_bib52","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/S0140-6736(10)60656-3","article-title":"Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis","volume":"375","author":"Jun","year":"2010","journal-title":"Lancet"},{"issue":"9500","key":"10.1016\/j.mcna.2011.11.006_bib53","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial","volume":"366","author":"Keech","year":"2005","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.mcna.2011.11.006_bib54","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1161\/01.CIR.98.19.2088","article-title":"Mechanism of action of fibrates on lipid and lipoprotein metabolism","volume":"98","author":"Staels","year":"1998","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.mcna.2011.11.006_bib55","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1161\/01.RES.0000127122.22685.0A","article-title":"Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells","volume":"94","author":"Marx","year":"2004","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.mcna.2011.11.006_bib56","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJMp1106688","article-title":"Fibrates in the treatment of dyslipidemias\u2013time for a reassessment","volume":"365","author":"Goldfine","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.mcna.2011.11.006_bib57","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJM198711123172001","article-title":"Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease","volume":"317","author":"Frick","year":"1987","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.mcna.2011.11.006_bib58","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM199908053410604","article-title":"Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group","volume":"341","author":"Rubins","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mcna.2011.11.006_bib59","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/01.CIR.102.1.21","article-title":"Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study","volume":"102","year":"2000","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.mcna.2011.11.006_bib60","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2337\/dc08-1543","article-title":"Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study","volume":"32","author":"Scott","year":"2009","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.mcna.2011.11.006_bib61","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/archophthalmol.2009.310","article-title":"Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudy","volume":"128","author":"Ambrosius","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.mcna.2011.11.006_bib62","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.pharmthera.2010.01.008","article-title":"Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk","volume":"126","author":"Chapman","year":"2010","journal-title":"Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.mcna.2011.11.006_bib63","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(86)80293-5","article-title":"Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin","volume":"8","author":"Canner","year":"1986","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.mcna.2011.11.006_bib64","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.amjcard.2004.09.013","article-title":"Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project)","volume":"95","author":"Canner","year":"2005","journal-title":"Am J Cardiol"},{"issue":"22","key":"10.1016\/j.mcna.2011.11.006_bib65","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa011090","article-title":"Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease","volume":"345","author":"Brown","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.mcna.2011.11.006_bib66","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1161\/01.CIR.0000148955.19792.8D","article-title":"Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins","volume":"110","author":"Taylor","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.mcna.2011.11.006_bib67","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ahj.2010.11.017","volume":"161","year":"2011","journal-title":"Am Heart J"},{"issue":"6A","key":"10.1016\/j.mcna.2011.11.006_bib68","doi-asserted-by":"crossref","first-page":"22C","DOI":"10.1016\/j.amjcard.2006.11.018","article-title":"Safety considerations with niacin therapy","volume":"99","author":"Guyton","year":"2007","journal-title":"Am J Cardiol"},{"issue":"14","key":"10.1016\/j.mcna.2011.11.006_bib69","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/archinte.162.14.1568","article-title":"Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of Niaspan trial","volume":"162","author":"Grundy","year":"2002","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.mcna.2011.11.006_bib70","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2796.2010.02333.x","article-title":"Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up","volume":"270","author":"Langsted","year":"2011","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.mcna.2011.11.006_bib71","unstructured":"Laufs U. The correlation of triglyceride and glucose tolerance with cardiovascular outcomes in patients with stable coronary artery disease: the Homburg Cream and Sugar study (HCS). Paper presented at: European Society of Cardiology Congress 2011. HOTLINE sessions at ESC, Paris (France), August 28, 2011."},{"issue":"4","key":"10.1016\/j.mcna.2011.11.006_bib72","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/01.mol.0000174154.61307.16","article-title":"Cord blood lipoproteins and prenatal influences","volume":"16","author":"Bansal","year":"2005","journal-title":"Curr Opin Lipidol"},{"issue":"2","key":"10.1016\/j.mcna.2011.11.006_bib73","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0002-8703(86)90296-6","article-title":"The triglyceride issue: a view from Framingham","volume":"112","author":"Castelli","year":"1986","journal-title":"Am Heart J"},{"issue":"19","key":"10.1016\/j.mcna.2011.11.006_bib74","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1001\/archinte.1993.00410190045006","article-title":"Plasma lipoprotein levels as predictors of cardiovascular death in women","volume":"153","author":"Bass","year":"1993","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.1016\/j.mcna.2011.11.006_bib75","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1445-5994.2005.00940.x","article-title":"Triglycerides\u00a0+ high-density-lipoprotein-cholesterol dyslipidaemia, a coronary risk factor in elderly women: the CArdiovascular STudy in the ELderly","volume":"35","author":"Mazza","year":"2005","journal-title":"Intern Med J"},{"issue":"18","key":"10.1016\/j.mcna.2011.11.006_bib76","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl","key":"10.1016\/j.mcna.2011.11.006_bib77","doi-asserted-by":"crossref","first-page":"L21","DOI":"10.1093\/eurheartj\/sui082","article-title":"What is the relationship between risk factor reduction and degree of weight loss?","volume":"7","author":"Van Gaal","year":"2005","journal-title":"Eur Heart J Suppl"},{"issue":"11S","key":"10.1016\/j.mcna.2011.11.006_bib78","doi-asserted-by":"crossref","first-page":"326S","DOI":"10.1038\/oby.2001.138","article-title":"Obesity and disease management: effects of weight loss on comorbid conditions","volume":"9","author":"Anderson","year":"2001","journal-title":"Obesity"},{"issue":"2","key":"10.1016\/j.mcna.2011.11.006_bib79","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/ajcn\/56.2.320","article-title":"Effects of weight reduction on blood lipids and lipoproteins: a meta- analysis","volume":"56","author":"Dattilo","year":"1992","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10.1016\/j.mcna.2011.11.006_bib80","first-page":"370","article-title":"Effect of controlled alcohol feeding on triglycerides in patients with outpatient \u2019alcohol hypertriglyceridemia\u2019","volume":"34","author":"Erkelens","year":"1980","journal-title":"J\u00a0Hum Nutr"},{"issue":"7224","key":"10.1016\/j.mcna.2011.11.006_bib81","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1136\/bmj.319.7224.1523","article-title":"Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors","volume":"319","author":"Rimm","year":"1999","journal-title":"BMJ"},{"issue":"15","key":"10.1016\/j.mcna.2011.11.006_bib82","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"9753","key":"10.1016\/j.mcna.2011.11.006_bib83","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.mcna.2011.11.006_bib84","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jama.1975.03240160024021","article-title":"Clofibrate and niacin in coronary heart disease","volume":"231","year":"1975","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.mcna.2011.11.006_bib85","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.4065\/81.12.1579","article-title":"Ezetimibe\/simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: the VYTAL study","volume":"81","author":"Goldberg","year":"2006","journal-title":"Mayo Clin Proc"},{"issue":"9177","key":"10.1016\/j.mcna.2011.11.006_bib86","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","article-title":"Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto miocardico","volume":"354","year":"1999","journal-title":"Lancet"},{"issue":"9567","key":"10.1016\/j.mcna.2011.11.006_bib87","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","article-title":"Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis","volume":"369","author":"Yokoyama","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2011.11.006_bib88","first-page":"1","article-title":"Effects of omega-3 fatty acids on cardiovascular risk factors and intermediate markers of cardiovascular disease","volume":"93","author":"Balk","year":"2004","journal-title":"Evid Rep Technol Assess (Summ)"},{"issue":"Suppl 5","key":"10.1016\/j.mcna.2011.11.006_bib89","doi-asserted-by":"crossref","first-page":"1645S","DOI":"10.1093\/ajcn\/65.5.1645S","article-title":"n-3 fatty acids and serum lipoproteins: human studies","volume":"65","author":"Harris","year":"1997","journal-title":"Am J Clin Nutr"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712511001222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712511001222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T18:20:22Z","timestamp":1593800422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712511001222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0025712511001222"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2011.11.006","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}